Foresite Capital Management VI LLC

Q3 2026 13F-HR Holdings

Location
West Hollywood, CA
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
22
Total value ($000)
$566,361
Net value change ($000)
-76,215 (-11.9%)
New positions
4
Sold out positions
5
Turnover %
27.9%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Korsana Biosciences, Inc. 45,813 NEW
Latigo Biotherapeutics, Inc. 36,803 NEW
VSTM 13,310 110.7%
Obsidian Therapeutics, Inc. 12,578 NEW
Parabilis Medicines, Inc. 4,915 18.0%
ZURA 4,654 175.3%
IRON 4,411 6212.7%
AVBP 4,379 41.8%
ENTXW 3,566 NEW
Top Reduces (Value $000, Stocks/ETFs)
ALMS -88,139 -73.7%
CLDX -32,734 -100.0%
CGON -18,810 -11.2%
ATAI -14,493 -100.0%
CRNX -7,933 -100.0%
HNGE -7,781 -42.5%
JBIO -7,244 -36.8%
CRVS -6,263 -22.9%
NERV -4,368 -39.6%
BEAM -3,257 -28.8%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type